GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Winston Medical Supply Co 6817.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

38.05

-2.31%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Winston Medical Supply Co

Its shares trade on Taipei Exchange under the ticker 6817.TWO. It has been listed since 24 February 2021. In the fiscal year to 31 December 2025, it reported revenue of TWD 700.1m and net income of TWD 117.3m. At that date it held total assets of TWD 780.9m and shareholders' equity of TWD 427.6m.

Winston Medical Supply Co., Ltd. engages in the manufacture and sale of medicines. The company is headquartered in Tainan, Tainan. The company went IPO on 2021-02-24. The firm's main business is the manufacturing, research and development and sales of scientifically-known drugs and medical aesthetics products. The firm's main products are eye medicine, oral medicine, hormone medicine, topical medicine, health food, cosmetics and others. Products are sold at home and abroad.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
24 Feb 2021

Leadership

Pay as last reported

  • Mr. Sen-Tien TsaiChairman of the Board, since 2021
  • Mr. Youzheng WangGeneral Manager, Director, Chief Information Security Officer, since 2012
  • Ms. Yijing ChenDeputy General Manager
  • Ms. Xinwen ZhangHead of Finance & Accounting, Corporate Governance Officer
  • Ms. Ya-Ling ChiangDirector
  • Mr. Shixun LinIndependent Director
  • Xiaojun LiuIndependent Director
  • Mr. Yaoxiang WangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Winston Medical Supply Co Ltd manufactures scientifically-known drugs and medical aesthetics products in Tainan, Taiwan.
  • The company's main products include eye medicine, oral medicine, and hormone medicine for global markets.
  • Winston Medical Supply Co Ltd has a strong focus on research and development for pharmaceutical innovation.

Weaknesses

  • The company's headquarters in Tainan, Taiwan, may limit its global market reach.
  • Winston Medical Supply Co Ltd relies on a narrow product range including health food and cosmetics.
  • The firm's IPO on 24 February 2021 indicates limited market history.

Opportunities

  • Expanding into the growing global pharmaceutical market offers significant growth potential.
  • The demand for medical aesthetics products in Asia presents a new market opportunity.
  • Winston Medical Supply Co Ltd can leverage its R&D capabilities to develop new products.

Threats

  • Competition from established pharmaceutical companies in Taiwan poses a threat to market share.
  • The global pharmaceutical industry faces regulatory challenges that could impact operations.
  • Economic downturns in key markets may reduce demand for non-essential medical products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.